Previous results have shown that drug uptake by cells is enhanced when the drug is bound to DNA. Chick embryo fibroblasts (CEF) treated with ethidium bromide (EB) exhibit inhibited cell multiplication, mitochondrial swelling and nucleolar segregation. However, EB-DNA treated CEF cells exhibit a much lower cytotoxicity than the EB-treated CEF cells and the mitochondrial and nucleolar alterations are reversible. Conversely, in Ehrlich ascites tumor cells exposed to EB or EB-DNA complexes, the toxicity of the DNA bound EB (as measured by inhibition of cell multiplication, nucleolar segregation, mitochondrial swelling and intramitochondrial inclusions) is more pronounced and appears earlier after treatment than the EB induced cytotoxicity. More recent results have shown that when EB was combined with double stranded RNA (poly r(A-U)) and then added to human foreskin fibroblasts (HSF), the 50% effective dose of the poly r(A-U) was 154-fold lower. The results of additional studies demonstrated that the enhanced antiviral activity was not due to superinduction of interferon, direct viral inactivation, or host cell cytotoxicity.